Microbot Medical
MBOT
30 hedge funds and large institutions have $5.19M invested in Microbot Medical in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 7 closing their positions.
225% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 4
9% less funds holding
Funds holding: 33 → 30 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
53% less capital invested
Capital invested by funds: $11.1M → $5.19M (-$5.86M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$589K |
| 2 |
Morgan Stanley
New York
|
+$121K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$109K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$87.1K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$80K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.85M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$176K |
| 3 |
ICAS
Investors Capital Advisory Services
Lynnfield,
Massachusetts
|
-$39K |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$25K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$17K |
MBOT Hedge Fund Activity: Q2 2015 in Review
30 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2015, worth a combined $5.19M — down 53% from $11.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MBOT and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 13 added.
The largest buyer was Vanguard Group, adding an estimated $589K. The largest seller was Sabby Management, cutting an estimated $1.85M.
- 30 institutional investors held Microbot Medical (MBOT) as of Q2 2015, down from 33 in Q1 2015.
- Funds reported $5.19M of Microbot Medical stock for Q2 2015, down 53% quarter-over-quarter.
- 4 funds opened new Microbot Medical positions in Q2 2015 and 7 closed out, a net change of -3 holders.
- The largest Microbot Medical buyer in Q2 2015 was Vanguard Group, an estimated $589K added.
- The largest Microbot Medical seller in Q2 2015 was Sabby Management, an estimated $1.85M sold.
Based on aggregated 13F filings for Q2 2015.